Möchten Sie immer auf dem neuesten Stand bleiben?

Azalea highlights Nature publication demonstrating in vivo CAR T engineering through site-specific genomic integration with durable anti-tumor activity.

Oral presentation of Ph 1a clinical data highlights potential best-in-class drug profile in heavily pretreated patients with PI3Ka-mutant metastatic breast cancer and other solid tumors Overall,...

MALVERN, Pa., March 18, 2026 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new space-grade, surface-mount common mode choke designed to provide EMI filtering and...

Fatboy Canada launches its Spring/Summer collection: modular lounges, dining sets, lighting, and bean bags to create the ultimate outdoor living space.

WALTHAM, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- Paragonix Technologies, a pioneer in organ transplant technologies and services, today announced the completion of the 1,000th clinical case using...

TAMPA, Fla. and LONDON, March 18, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice...

ACR-368, a CHK1/2 inhibitor in a registrational-intent Phase 2b study, showed potent preclinical synergy with Topoisomerase 1 (Topo 1) inhibitors, commonly used payloads in antibody-drug conjugates...

New clinical data from Phase 1 trial of ZW191 to be presented in an oral presentation on April 21Preclinical data highlight combination potential for ZW191, a folate receptor alpha (FR⍺)-targeting...

OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital

SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies...